Novartis is proud to share that CEO Vas Narasimhan, M.D., has been named to the 2025 TIME100 Health list—recognizing 100 of the most influential people driving the future of global health.

Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.

Fabhalta APPULSE-PNH full results build on Phase III program, reporting new data from expanded PNH population in adults switching from anti-C5 Ianalumab Phase II data in immune thrombocytopenia and ...

Health disparities in Canada go beyond individual health issues - they underscore deeper societal injustices that undermine our social fabric. These inequities highlight the existence of systemic ...

• Applications are now being accepted, with $500,000 in grants to be awarded to projects focused on improving health equity in Canada Montreal, Quebec, May 14, 2025 – Novartis Pharmaceuticals Canada ...

While the exact reason for this gender imbalance remains unknown, researchers are exploring contributing factors, including hormones, environmental triggers, and antibody levels. 3 Nevertheless, the ...

Job Title Sort ascending Business Location Site Date Posted Praktikant Medical ab 112025 Early Career (Befristet), Full time Universal Hierarchy Node Germany Nuremberg (Non-Sales Force) (Novartis ...

To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.

Explore opportunities with Novartis below.

The Reimagining Care Pathways CWP is a service offered by Novartis, which comprises a series of workshops, with the aim of providing pathway mapping support to the CW Partner to: Identify potential ...